(searched for: doi:10.17352/2455-2976.000173)
Published: 4 November 2021
Journal of Cardiovascular Medicine and Cardiology pp 069-071; https://doi.org/10.17352/2455-2976.000173
Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disease characterized by progressive glicosphingolipid accumulation in multiple organs, due to α-galactosidase a deficiency . It is considered a rare disease although newborn genetic screening showed non-negligible prevalence (∼1:3.900) . Cardiac manifestations include progressive Left Ventricular (LV) Hypertrophy (LVH), which may be extreme and provoke both reduced stroke volume and dynamic LV outflow tract obstruction [2-6].